OOIR: Observatory of International Research

Papers

(The TQCC of Progress in Retinal and Eye Research is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Cell identity changes in ocular surface Epithelia	385
The neuroimmune interface in retinal regeneration	280
In vivo application of base and prime editing to treat inherited retinal diseases	217
Posterior capsule opacification: What's in the bag?	217
Non-vasogenic cystoid maculopathies	212
Immunological aspects of RPE cell transplantation	204
Promises and pitfalls of evaluating photoreceptor-based retinal disease with adaptive optics scanning light ophthalmoscopy (AOSLO)	193
Animal models for the evaluation of retinal stem cell therapies	150
Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions	144
Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives	128
Editorial Board	124
Mitophagy in the retina: Viewing mitochondrial homeostasis through a new lens	123
Corneal stromal repair and regeneration	123
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas	121
Structure and function of ABCA4 and its role in the visual cycle and Stargardt macular degeneration	112
Central serous chorioretinopathy: An evidence-based treatment guideline	111
Editorial Board	103
Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO)	100
Homeostatic plasticity in the retina	100
A paradigm shift in retinal detachment repair: The concept of integrity	96
Risk factors, clinical features and treatment of Behçet's disease uveitis	90
Myocilin misfolding and glaucoma: A 20-year update	90
Gene-independent therapeutic interventions to maintain and restore light sensitivity in degenerating photoreceptors	87
Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective	87
Photocoagulation for retinal vein occlusion	84

Squishy matters – Corneal mechanobiology in health and disease	84
Uncoupling proteins in the mitochondrial defense against oxidative stress	81
Cell fate decisions, transcription factors and signaling during early retinal development	80
Protection against corneal hyperosmolarity with soft-contact-lens wear	79
The endoplasmic reticulum: Homeostasis and crosstalk in retinal health and disease	79
Editorial Board	79
Patient derived stem cells for discovery and validation of novel pathogenic variants in inherited retinal disease	78
The retinal pigmentation pathway in human albinism: Not so black and white	74
How gut microbiota may impact ocular surface homeostasis and related disorders	73
RNA-targeting strategies as a platform for ocular gene therapy	72
Approaches for corneal endothelium regenerative medicine	70
Photoreceptor cells and RPE contribute to the development of diabetic retinopathy	68
The vital role for nitric oxide in intraocular pressure homeostasis	66
Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration	66
Clinical vision and molecular loss: Integrating visual psychophysics with molecular genetics reveals key details of normal and abnormal visual processing	64
Cellular component transfer between photoreceptor cells of the retina	61
Corrigendum to “Optical coherence tomography in the management of diabetic macular oedema” [Prog. Retin. Eye Res. 98 (2024) 101220]	61
Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs’ endothelial corneal dystrophy	61
Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence	60
Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives	60
Optical coherence tomography angiography in diabetic retinopathy	60
Editorial Board	58
Rhodopsin, light-sensor of vision	58
Corneal endothelial dysfunction: Evolving understanding and treatment options	58
Regulation of lens water content: Effects on the physiological optics of the lens	58
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye	57
Female carriers of X-linked inherited retinal diseases – Genetics, diagnosis, and potential therapies	56
Retinal pigment epithelium 65 kDa protein (RPE65): An update	56
Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation	56
The retinal pigment epithelium: Development, injury responses, and regenerative potential in mammalian and non-mammalian systems	56
Retinal TRP channels: Cell-type-specific regulators of retinal homeostasis and multimodal integration	55
Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma	54
Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity	54
Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)	53
Zinn's zonule	53
Quantitative approaches in multimodal fundus imaging: State of the art and future perspectives	53
Bacterial keratitis: identifying the areas of clinical uncertainty	52
VEGFR1 signaling in retinal angiogenesis and microinflammation	51
The role of CFTR in the eye, and the effect of early highly effective modulator treatment for cystic fibrosis on eye health	50